Marshall Wace North America’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-159,157
| Closed | -$2.05M | – | 1519 |
|
|
2021
Q2 | $2.05M | Buy |
159,157
+84,047
| +112% | +$1.08M | 0.01% | 783 |
|
|
2021
Q1 | $840K | Buy |
+75,110
| New | +$840K | ﹤0.01% | 1062 |
|
|
2020
Q3 | – | Sell |
-148,924
| Closed | -$1.54M | – | 1338 |
|
|
2020
Q2 | $1.54M | Buy |
148,924
+142,155
| +2,100% | +$1.47M | 0.01% | 646 |
|
|
2020
Q1 | $68K | Sell |
6,769
-48,369
| -88% | -$486K | ﹤0.01% | 1049 |
|
|
2019
Q4 | $735K | Sell |
55,138
-11,611
| -17% | -$155K | ﹤0.01% | 762 |
|
|
2019
Q3 | $573K | Buy |
66,749
+5,772
| +9% | +$49.5K | ﹤0.01% | 792 |
|
|
2019
Q2 | $667K | Sell |
60,977
-9,535
| -14% | -$104K | ﹤0.01% | 838 |
|
|
2019
Q1 | $799K | Buy |
+70,512
| New | +$799K | 0.01% | 707 |
|
|
2018
Q3 | – | Sell |
-262,318
| Closed | -$4.2M | – | 1132 |
|
|
2018
Q2 | $4.2M | Buy |
+262,318
| New | +$4.2M | 0.02% | 563 |
|